14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -1.850 2 days ( -6.72 % )
Last Price $0.254 6.72 %
High/ Low $0.220 - $0.278 25.12%
Chg 7 Days 12.04 % $0.227 $0.254
Chg 30 Days -28.02 % $0.353 $0.254
Chg 12 mos -75.10 % $1.02 $0.254
Trend - 3 mos -23.47 % Width: 89.31 %
Trend - 12 mos -64.06 % Width: 1,644.03 %
Pred. range - 3 mos $0.130 - $0.246 -48.89 % - -3.25 %
Pred. range - 12 mos $0.0095 - $0.166 -96.24 % - -34.46 %
Short MA avg 3 mos Buy Jun 17, 2024 - 4 days
Long MA avg 3 mos Buy Jun 17, 2024 - 4 days
Short/Long MA avg 3 mos Sell Jun 07, 2024 - 10 days
Short MA avg 12 mos Sell Jun 03, 2024 - 14 days
Long MA avg 12 mos Buy May 21, 2024 - 22 days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy Jun 17, 2024 - 4 days
Bollinger Buy Apr 16, 2024 - 47 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Inmed Pharmaceuticals Inc.

Inmed Pharmaceuticals. InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it en... INM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT